Potent antagonism of 5-HT3 and 5-HT6 receptors by olanzapine

This publication has 50 references indexed in Scilit:

• Use of the Selective Serotonin 3 Receptor Antagonist Ondansetron in the Treatment of Neuroleptic-Induced Tardive Dyskinesia
  American Journal of Psychiatry, 2000
• Preclinical and clinical pharmacology of the 5-HT3 receptor antagonists
  Scandinavian Journal of Rheumatology, 2000
• Efficacy and tolerability of tropisetron in primary fibromyalgia - a highly selective and competitive 5-HT3 receptor antagonist
  Scandinavian Journal of Rheumatology, 2000
• 5-HT 3 receptor antagonists
  Expert Opinion on Investigational Drugs, 1999
• Comparison of metoclopramide and ondansetron for the prevention of nausea and vomiting after intrathecal morphine
  European Journal of Anaesthesiology, 1997
• Tardive Dyskinesia as a Result of Long-Term Prochlorperazine Use
  Southern Medical Journal, 1996
• Single-Blind Study of the Effects of Intravenous Dolasetron Mesylate Versus Ondansetron on Electrocardiographic Parameters in Normal Volunteers
  Journal of Cardiovascular Pharmacology, 1996
• Chiral recognition of the angiotensin II (AT1) receptor by a highly potent phenoxyproline octanoamide
  Bioorganic & Medicinal Chemistry Letters, 1994
• Successful control of intractable nausea and vomiting requiring combined ondansetron and haloperidol in a patient with advanced cancer
  Journal of Pain and Symptom Management, 1994
• Efficacy of Ondansetron (Gr 38032F) and the Role of Serotonin in Cisplatin-Induced Nausea and Vomiting
  New England Journal of Medicine, 1990